Mayo Clinic Proceedings Home

Treatment of Parapsoriasis and Mycosis Fungoides: The Role of Psoralen and Long-Wave Ultraviolet Light A (PUVA)

      Psoralen and long-wave ultraviolet light A (PUVA) was used to treat 12 patients with parapsoriasis and 19 patients with mycosis fungoides. Excellent results were obtained in all 12 patients with parapsoriasis: 8 patients had complete clearing, 3 had more than 80% improvement, and 1 had considerable improvement. The response to PUVA in patients with mycosis fungoides varied according to the stage of the disease. Of 10 patients with early disease (stage I or II), 7 had complete clearing and the 3 others had more than 80% improvement. The nine patients with more advanced disease generally did not respond well to PUVA, with the exception of one patient with stage IV disease and one with stage V disease. PUVA may be the treatment of choice for parapsoriasis and is highly effective in the early stages of mycosis fungoides.
      To read this article in full you will need to make a payment

      REFERENCES

        • Lambert WC
        • Everett MA
        The nosology of parapsoriasis.
        J Am Acad Dermatol. 1981; 5: 373-395
        • Van Scott EJ
        • Kalmanson JD
        Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2): control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
        Cancer. 1973; 32: 18-30
        • Molin L
        • Thomsen K
        • Volden G
        • Groth O
        • Fischer T
        • Nordentoft A
        • Zachariae H
        Aspects of the treatment of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
        Cutis. 1980; 25: 155-161
        • Epstein Jr, EH
        • Levin DL
        • Croft Jr, JD
        • Lutzner MA
        Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings.
        Medicine (Baltimore). 1972; 51: 61-72
        • Melski JW
        • Tanenbaum L
        • Parrish JA
        • Fitzpatrick TB
        • Bleich HL
        Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.
        J Invest Dermatol. 1977; 68: 328-335
        • Powell FC
        • Muller SA
        Psoralens and ultraviolet A therapy of pityriasis lichenoides.
        J Am Acad Dermatol. 1984; 10: 59-64
        • Lambert WC
        Parapsoriasis.
        in: Fitzpatrick TB Eisen AZ Wolff K Freedberg IM Austen KF Dermatology in General Medicine: Textbook and Atlas. Second edition. McGraw-Hill Book Company, New York1979: 808-817
        • Lepine EM
        Parapsoriasis: a re-evaluation.
        Cutis. 1974; 14: 729-734
        • Osmundsen PE
        Parapsoriasis en plaques: a follow-up study.
        Acta Derm Venereol (Stockh). 1968; 48: 345-354
      1. Palmer DD: Atrophic (poikiloderma vasculare atrophicans) and extensive (retiform parapsoriasis) forms of parapsoriasis. Thesis, University of Minnesota, 1962

        • Samman PD
        Reticuloses.
        in: Rook AJ Wilkinson DS Ebling FJG Third edition. Textbook of Dermatology. Vol 2. Blackwell Scientific Publications, Oxford1979: 1535-1558
        • Winkelmann RK
        • Lorenc E
        Treatment of acute parapsoriasis with corticotropin (ACTH).
        Arch Dermatol. 1959; 79: 512-515
        • Shelley WB
        • Griffith RF
        Pityriasis lichenoides et varioliformis acuta: a report of a case controlled by a high dose of tetracycline.
        Arch Dermatol. 1969; 100: 596-597
        • Shavin JS
        • Jones TM
        • Alton JK
        • Abele DC
        • Smith Jr, JG
        Mucha- Habermann's disease in children: treatment with erythromycin.
        Arch Dermatol. 1978; 114: 1679-1680
        • Verallo VM
        • Haserick JR
        Mucha-Habermann's disease simulating lymphoma cutis: report of two cases.
        Arch Dermatol. 1966; 94: 295-299
        • McMillan EM
        • Everett MA
        Pityriasis lichenoides et varioliformis acuta.
        in: Maddin S Carruthers A Current Dermatologic Therapy. WB Saunders Company, Philadelphia1982: 362-364
        • Mandrea E
        Successful treatment of parapsoriasis en plaques with 2-4-dinitrochlorobenzene (letter to the editor).
        Arch Dermatol. 1971; 103: 560-561
      2. Everett MA, Headington JT: Parapsoriasis. In Clinical Dermatology. Vol 1. DJ Demis, RL Dobson, J McGuire. 1982, Unit 6

        • Takada Y
        • Irisawa K
        • Kawada A
        Heliotherapy of pityriasis lichenoides chronica.
        Jpn J Dermatol. 1977; 4: 91-94
        • Milstein HJ
        • Vonderheid EC
        • Van Scott EJ
        • Johnson WC
        Home ultraviolet phototherapy of early mycosis fungoides: preliminary observations.
        J Am Acad Dermatol. 1982; 6: 355-362
        • Vella Briffa D
        • Warin AP
        • Calnan CD
        Parakeratosis variegata: a report of two cases and their treatment with PUVA.
        Clin Exp Dermatol. 1979; 4: 537-541
        • Brenner W
        • Gschnait F
        • Honigsmann H
        • Fritsch P
        Erprobungvon PUVA bei verschiedenen Dermatosen.
        Hautarzt. 1978; 29: 541-544
        • Thivolet J
        • Ortonne JP
        • Gianadda B
        • Gianadda E
        Photochimio therapie orale du parapsoriasis en gouttes.
        Dermatologica. 1981; 163: 12-18
        • Hofmann C
        • Weissmann I
        • Plewig G
        Pityriasis lichenoides chronica: eine neue Indikation zur PUVA-Therapie?.
        Dermatologica. 1979; 159: 451-460
        • Boelen RE
        • Faber WR
        • Lambers JCCA
        • Cormane RH
        Long-term follow-up of photochemotherapy in pityriasis lichenoides.
        Acta Dermatovener. 1982; 62: 442-444
        • Oberste-Lehn H
        • Mortazawi SAM
        Therapeutische Ergebnisse bei der Anwendung von 8-Methoxypsoralen (8-MOP) und UVA.
        Z Hautkr. 1975; 50: 559-571
        • Farber EM
        • Zackheim HS
        • McClintock RP
        • Cox Jr, AJ
        Treatment of mycosis fungoides: with various strengths of fluocinolone acetonide cream.
        Arch Dermatol. 1968; 97: 165-172
        • Van Scott EJ
        • Winters PL
        Responses of mycosis fungoides to intensive external treatment with nitrogen mustard.
        Arch Dermatol. 1970; 102: 507-514
        • Waldorf DS
        • Haynes HA
        • Van Scott EJ
        Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
        Ann Intern Med. 1967; 67: 282-290
        • Vonderheid EC
        • Van Scott EJ
        • Johnson WC
        • Grekin DA
        • Asbell SO
        Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
        Arch Dermatol. 1977; 113: 454-462
        • Hamminga B
        • Noordijk EM
        • van Vloten WA
        Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
        Arch Dermatol. 1982; 118: 150-153
        • Zackheim HS
        Treatment of mycosis fungoides with topical nitrosourea compounds.
        Arch Dermatol. 1972; 106: 177-182
        • Fromer JL
        • Johnston DO
        • Salzman FA
        • Trump JG
        • Wright KA
        Management of lymphoma cutis with low megavolt electron beam therapy: nine year follow-up in 200 cases.
        South Med J. 1961; 54: 769-776
        • Fuks ZY
        • Bagshaw MA
        • Farber EM
        Prognostic signs and the management of the mycosis fungoides.
        Cancer. 1973; 32: 1385-1395
        • Szur L
        Radiotherapy of the skin reticuloses.
        Br J Dermatol. 1964; 76: 10-20
        • Grollman Jr, JH
        • Bierman SM
        • Ottoman RE
        • Morgan JE
        • Horns J
        Total-skin electron-beam therapy of lymphoma cutis and generalized psoriasis: clinical experiences and adverse reactions.
        Radiology. 1966; 87: 908-915
        • Spittle MF
        Electron-beam therapy in England.
        Cancer Treat Rep. 1979; 63: 639-641
        • Nisce LZ
        • Safai B
        Once weekly total-skin electron-beam therapy for mycosis fungoides: 7 years' experience.
        Cancer Treat Rep. 1979; 63: 633-638
        • Hoppe RT
        • Cox RS
        • Fuks Z
        • Price NM
        • Bagshaw MA
        • Farber EM
        Electron-beam therapy for mycosis fungoides: the Stanford University experience.
        Cancer Treat Rep. 1979; 63: 691-700
        • Le Bourgeois JP
        • Bridier A
        • Bounik H
        • Schlienger M
        Whole cutaneous irradiation in mycosis fungoides with 55KV x-rays: technical study.
        Bull Cancer (Paris). 1977; 64: 313-322
        • Wiskemann A
        • Buck C
        Radiotherapy of mycosis fungoides: twenty years of experience with teleroentgen and low-voltage X-ray therapy.
        J Dermatol Surg Oncol. 1978; 4: 606-610
        • Van Scott EJ
        • Grekin DA
        • Kalmanson JD
        • Vonderheid EC
        • Barry WE
        Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
        Cancer. 1975; 36: 1613-1618
        • Grozea PN
        • Jones SE
        • McKelvey EM
        • Coltman Jr, CA
        • Fisher R
        • Haskins CL
        Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
        Cancer Treat Rep. 1979; 63: 647-653
        • Edelson RL
        Cutaneous T-cell lymphoma.
        in: Moschella S Dermatology Up date. Elsevier Press, New York1979: 195-207
        • Edelson RL
        Cutaneous T cell lymphoma: mycosis fungoides, Sezary syndrome, and other variants.
        J Am Acad Dermatol. 1980; 2: 89-106
        • Shelley WB
        Demethylchlortetracycline and griseofulvin as examples of specific treatment for mycosis fungoides.
        Br J Dermatol. 1981; 104: 477-480
        • Thestrup-Pedersen K
        • Grunnet E
        • Zachariae H
        Transfer factor therapy in mycosis fungoides: a double-blind study.
        Acta Dermatovener. 1982; 62: 47-53
        • Edelson RL
        • Brown JA
        • Grossman ME
        • Hardy MA
        Anti-thymocyte globulin in treatment of T-cell lymphoma (letter to the editor).
        Lancet. 1977; 2: 249-250
        • Miller RA
        • Levy R
        Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody.
        Lancet. 1981; 1: 226-230
        • Gilchrest BA
        • Parrish JA
        • Tanenbaum L
        • Haynes HA
        • Fitzpatrick TB
        Oral methoxsalen photochemotherapy of mycosis fungoides.
        Cancer. 1976; 38: 683-689
        • Bleehen SS
        • Vella Briffa D
        • Warin AP
        Photochemotherapy in mycosis fungoides.
        Clin Exp Dermatol. 1978; 3: 377-387
        • Rotstein H
        • Butler JM
        • Czarnecki DB
        • O'Brien TJ
        • George MT
        The treatment of mycosis fungoides with PUVA.
        Aust J Dermatol. 1980; 21: 100-104
        • Roenigk HH
        Photochemotherapy for mycosis fungoides.
        Arch Dermatol. 1977; 113: 1047-1051
        • Lowe NJ
        • Cripps DJ
        • Dufton PA
        • Vickers CFH
        Photochemotherapy for mycosis fungoides: a clinical and histological study.
        Arch Dermatol. 1979; 115: 50-53
        • Warin AP
        Photochemotherapy in the treatment of psoriasis and mycosis fungoides.
        Clin Exp Dermatol. 1981; 6: 651-657
        • Konrad K
        • Gschnait F
        • Honigsmann H
        • Fritsch P
        • Wolff K
        Photochemotherapie bei Mycosis fungoides.
        Hautarzt. 1978; 29: 191-197
        • Gilchrest BA
        Methoxsalen photochemotherapy for mycosis fungoides.
        Cancer Treat Rep. 1979; 63: 663-667
        • Molin L
        • Thomsen K
        • Volden G
        • Groth O
        Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
        Acta Dermatovener. 1980; 61: 47-51
        • Molin L
        • Thomsen K
        • Volden G
        • Groth O
        Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
        Acta Dermatovener. 1981; 61: 52-54
        • Abel EA
        • Deneau DG
        • Farber EM
        • Price NM
        • Hoppe RT
        PUVA treatment of erythrodermic and plaque type mycosis fungoides.
        J Am Acad Dermatol. 1981; 4: 423-429
        • Hofmann C
        • Burg G
        • Plewig G
        • Braun-Falco O
        Photochemother apie kutaner Lymphome.
        Dtsch Med Wochenschr. 1977; 18: 675-679
        • Grupper C
        • Berretii B
        • Schnitzler L
        • Bensoussan D
        Traitement du mycosis fongoide par la PUVAtherapie: a propos de 18 cas.
        Ann Dermatol Venereol (Paris). 1928; 105: 291-298
        • Niemi K-M
        PUVA treatment in mycosis fungoides.
        Dermatologica. 1979; 158: 462-467
        • Taniguchi S
        • Horio T
        • Komura J
        Mycosis fungoides in the tumor stage treated by PUVA: a successful trial in a 12-year-old girl.
        Dermatologica. 1980; 160: 409-413
        • Honigsmann H
        • Brenner W
        • Rauschmeier W
        • Konrad K
        • Wolff K
        Photochemotherapy for cutaneous T cell lymphoma.
        J Am Acad Dermatol. 1984; 10: 238-245
        • Roenigk Jr, HH
        Stress aggressive treatment of advanced M. fungoides.
        Skin Allergy News. 1982; 13: 5
        • Austad J
        • Mørk N-J
        Effects of PUVA on delayed hypersensitivity in the guinea-pig.
        Br J Dermatol. 1981; 105: 641-644
        • Strauss GH
        • Greaves M
        • Price M
        • Bridges BA
        • Hall-Smith P
        • Vella-Briffa D
        Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy: possible basis for pseudo-promoting action in skin carcinogenesis?.
        Lancet. 1980; 2: 556-559
        • Volden G
        • Molin L
        • Thomsen K
        PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides.
        Br Med J. 1978; 2: 865-866
        • Du Vivier A
        • Vollum Dl
        Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
        Br J Dermatol. 1980; 102: 319-322
        • Pathak MA
        • Kramer DM
        • Fitzpatrick TB
        Photobiology and photochemistry of furocoumarins (psoralens).
        in: Pathak MA Harber LC Seiji M Kukita A Sunlight and Man: Normal and Abnormal Photobiologic Responses. University of Tokyo Press, Tokyo1974: 335-368
        • Kruger JP
        • Christophers E
        • Schlaak M
        Dose-effects of 8-methoxy psoralen and UVA in cultured human lymphocytes.
        Br J Dermatol. 1978; 98: 141-144
        • Friedmann PS
        • Rogers S
        Photochemotherapy of psoriasis: DNA damage in blood lymphocytes.
        J Invest Dermatol. 1980; 74: 440-443
        • Aberer W
        • Schuler G
        • Stingl H
        • Honigsmann H
        • Wolff K
        Effects of UV-light on epidermal Langerhans cells (abstract).
        J Invest Dermatol. 1980; 74: 458
        • Bleehan SS
        Light and electron microscopic studies on mycosis fungoides during long-term PUVA treatment.
        in: Goos M Christopher E Lymphoproliferative Diseases of the Skin. Springer-Verlag, New York1982: 110-116
        • Mackie RM
        Onycholysis occurring during PUVA therapy.
        Clin Exp Dermatol. 1979; 4: 111-113
        • Proctor MS
        • Price NM
        • Cox AJ
        • Hoppe RT
        Subcutaneous mycosis fungoides.
        Arch Dermatol. 1978; 114: 1326-1328
        • Fischer T
        • van Vloten WA
        • Volden G
        Internal dissemination of mycosis fungoides despite successful local therapy.
        Acta Dermatovener. 1978; 58: 88-89
        • Molin L
        • Skogh M
        • Volden G
        Successful PUVA-treatment in the tumour stage of mycosis fungoides associated with the appearance of lesions in organs other than the skin (letter to the editor).
        Acta Dermatovener. 1978; 58: 189-190